Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01361633 · ClinicalTrials.gov registry record · Phase 2
The Cognitive Enhancing Effects of D-Cycloserine Among Non-Demented Elderly
A Phase 2 study, sponsored by Hartford Hospital.
- Completed
- Registry status
- Phase 2
- Development phase
- 51
- Enrollment target
NCT01361633 is a Phase 2 study that has completed, run by Hartford Hospital. The registered enrollment target is 51 participants.
The verdict
NCT01361633, a Phase 2 study, has completed, sponsored by Hartford Hospital.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 51 participants
- Enrollment target
Study Summary
The goal of this study is to determine whether a study medication (d-cycloserine) improves the ability of older adults to perform on tests of neuropsychological functioning. Tests of neuropsychological functioning assess attention, memory, and executive functioning skills (for example, problem-solving, planning and organizing skills). It was hypothesized that participants who received study medication would perform better on neuropsychological tests than would participants who received the sugar pill.
Interventions
- DRUG d-cycloserine
- DRUG Sugar Pill
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 51 participants |
| Start Date | 2008-01 |
| Est. Completion | 2009-02 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01361633
The ClinicalTrials.gov registry entry for NCT01361633 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 51 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Hartford Hospital, which has 75 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which d-cycloserine is the first listed.
NCT01361633 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01361633 about?
NCT01361633 is a clinical study titled "The Cognitive Enhancing Effects of D-Cycloserine Among Non-Demented Elderly". The goal of this study is to determine whether a study medication (d-cycloserine) improves the ability of older adults to perform on tests of neuropsychological functioning. Tests of neuropsychological functioning assess attention, memory, and executive functioning skills (for example, problem-solvi...
What is the current status of trial NCT01361633?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 51 participants. The study started on 2008-01. Estimated completion is 2009-02.
What interventions are being tested in trial NCT01361633?
The interventions under investigation include: d-cycloserine (DRUG), Sugar Pill (DRUG).
Who is sponsoring clinical trial NCT01361633?
This trial is sponsored by Hartford Hospital, which has 75 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.